Ultralife's MACD Death Cross and Bearish Marubozu trigger negative momentum.
PorAinvest
miércoles, 13 de agosto de 2025, 12:51 pm ET1 min de lectura
ULBI--
The company's EPS for the quarter was 5 cents, significantly lower than the same period last year's 22 cents. The revenue shortfall was attributed to delayed orders, tariffs, and margin compression, as cited by CEO Mike Manna [2]. Analysts had lowered their mean earnings estimate by about 33.3% over the last three months, reflecting growing concerns about the company's performance [1].
Technical indicators also signal a potential continuation of the downtrend. According to the 15-minute chart for Ultralife, the Moving Average Convergence Divergence (MACD) indicator formed a death cross at 09:45 on August 7, 2025, suggesting a potential shift in momentum towards the downside [2]. Additionally, the KDJ (KST Divergence Indicator) also triggered a death cross at the same time, reinforcing the bearish signal [2]. These indicators suggest that the stock price has the potential to continue falling, potentially leading to further decreases in the stock price.
Investors should monitor key levels, such as the 200-day moving average at $7.08 and the support level at $6.28, as a close below $6.28 could trigger a test of the 52-week low [2]. While the CEO hinted at potential recovery in the second half of 2025, near-term risks remain elevated, and caution is warranted [2].
References:
[1] https://www.tradingview.com/news/reuters.com,2025:newsml_L8N3TZ2IL:0-ultralife-corp-reports-results-for-the-quarter-ended-june-30-earnings-summary/
[2] https://www.ainvest.com/news/ultralife-plunges-20-34-fueling-selloff-earnings-disappointment-2508/
Ultralife's 15-minute chart has exhibited a MACD Death Cross and a Bearish Marubozu at 08/13/2025 12:45, indicating a potential for the stock price to continue its downward trajectory. The presence of sellers in control of the market suggests a continuation of bearish momentum.
Ultralife Corp (ULBI) reported its second-quarter earnings on August 7, 2025, with adjusted earnings per share (EPS) of 7 cents, falling short of the expected 14 cents per share. Revenue rose 13% to $48.56 million but missed the analysts' estimate of $51.00 million [1]. The stock price reacted negatively, falling by 9.1% in the quarter and gaining 9.5% year-to-date [1].The company's EPS for the quarter was 5 cents, significantly lower than the same period last year's 22 cents. The revenue shortfall was attributed to delayed orders, tariffs, and margin compression, as cited by CEO Mike Manna [2]. Analysts had lowered their mean earnings estimate by about 33.3% over the last three months, reflecting growing concerns about the company's performance [1].
Technical indicators also signal a potential continuation of the downtrend. According to the 15-minute chart for Ultralife, the Moving Average Convergence Divergence (MACD) indicator formed a death cross at 09:45 on August 7, 2025, suggesting a potential shift in momentum towards the downside [2]. Additionally, the KDJ (KST Divergence Indicator) also triggered a death cross at the same time, reinforcing the bearish signal [2]. These indicators suggest that the stock price has the potential to continue falling, potentially leading to further decreases in the stock price.
Investors should monitor key levels, such as the 200-day moving average at $7.08 and the support level at $6.28, as a close below $6.28 could trigger a test of the 52-week low [2]. While the CEO hinted at potential recovery in the second half of 2025, near-term risks remain elevated, and caution is warranted [2].
References:
[1] https://www.tradingview.com/news/reuters.com,2025:newsml_L8N3TZ2IL:0-ultralife-corp-reports-results-for-the-quarter-ended-june-30-earnings-summary/
[2] https://www.ainvest.com/news/ultralife-plunges-20-34-fueling-selloff-earnings-disappointment-2508/
Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios